Trial
NCT04217057
Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Washington University School of Medicine
Collaborators
National Institutes of Health (NIH); National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Condition
Head and Neck Cancer
Intervention
64Cu-DOTA-ECL1i
Why stopped
Insufficient funding/staff
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-19